Hemophilia Association of New Jersey

Resources >>Protocols >>Newark Beth Israel Medical Center


 

Protocols November, 2011
Newark Beth Israel Medical Center & Children's Hospital of New Jersey
Comprehensive Hemophilia Treatment Center

 

 
     

Hemophilia

     
NAME OF PROTOCOL   SPONSOR STATUS
       
Von Willebrand Disease  

 

 

A Phase 3 Clinical Study to determine the safety and efficacy of rVWF:FVIII and  rVWF in the treatment and prevention of bleeding episodes in subjects diagnosed with von Willebrand disease Baxter

Open

       
       
       
       

Treatment Centers Case Management Public Education Legislation